Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Vasc Surg ; 24(8): 1102-9, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21035702

ABSTRACT

BACKGROUND: Internal iliac arteriovenous malformations (AVM) are difficult to treat. Arterial embolization is chosen in most cases but the angio-architecture of these arteriovenous shunts can provide an explanation for the several reported failures. We report the long-term results of peroperative intravenous embolization. METHODS: Between the years 1980 and 2008, seven patients were treated for complex and symptomatic internal AVM. These patients underwent a surgery which involved massive embolization of the venous hypogastric compartment, followed by the ligation of the hypogastric vein at its origin. RESULTS: There were no deaths reported in this group. The mean follow-up was 7 years (range: 10 months-12 years), with no cases of recurrences found. Computed tomographic scans of controls with reconstruction did not show any residual arteriovenous shunts. CONCLUSION: Intravenous embolization of the internal iliac AVM is a therapeutic strategy which is well adapted to the special angio-architecture of the arteriovenous shunts. Clinical and anatomic results have confirmed the validity of this strategy.


Subject(s)
Arteriovenous Malformations/therapy , Embolization, Therapeutic , Iliac Vein/surgery , Pelvis/blood supply , Vascular Surgical Procedures , Adult , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/surgery , Embolization, Therapeutic/adverse effects , Female , France , Humans , Iliac Artery/abnormalities , Iliac Artery/diagnostic imaging , Iliac Artery/surgery , Iliac Vein/abnormalities , Iliac Vein/diagnostic imaging , Ligation , Male , Middle Aged , Reoperation , Retrospective Studies , Time Factors , Tomography, X-Ray Computed , Treatment Outcome , Vascular Surgical Procedures/adverse effects
2.
J Vasc Surg ; 42(6): 1190-7, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16376213

ABSTRACT

OBJECTIVE: In France, despite a high intake of dietary cholesterol and saturated fat, the cardiovascular death rate is one of the lowest among developed countries. This "French paradox" has been postulated to be related to the high red wine intake in France. The aim of this study was to determine the effects of resveratrol, a major polyphenol component of red wine, on vascular smooth muscle cell (SMC) proliferation in vitro. METHODS: SMCs were exposed to 10(-6) to 10(-4) M resveratrol and cell proliferation was assessed by cell counting. Cell cycle analysis was done by treating cells with propidium iodide followed by flow-activated cell sorting. Apoptosis was determined by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling staining. RESULTS: We demonstrate that resveratrol inhibited bovine aortic SMC proliferation in a dose-dependent manner. The lowest concentration of resveratrol resulting in a significant decrease in SMC proliferation compared with control was 10(-5) M. By flow cytometry, we observed a block in the G1-S phase of the SMC cycle. Resveratrol treatment also resulted in a dose-dependent apoptosis of SMCs but had no effects on SMC morphology. CONCLUSION: The results indicated that vascular SMC proliferation could be inhibited by resveratrol through a block on G1-S phase and by an increase in apoptosis. It supports the conjecture that red wine consumption may have a beneficial effect on cardiovascular mortality. CLINICAL RELEVANCE: Our results suggest that resveratrol inhibits, in a dose-dependent manner, smooth muscle cell proliferation, which may help to partially explain a beneficial effect of wine drinking. This inhibition is related to an early block in the cell cycle and also to a dose-dependent apoptotic effect. The present study demonstrates that resveratrol not only is an indirect marker of a healthy life style and alimentation but may also be directly responsible for the French paradox.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Antioxidants/pharmacology , Aorta, Thoracic/cytology , Apoptosis/physiology , Cell Proliferation/drug effects , Muscle, Smooth, Vascular/cytology , Stilbenes/pharmacology , Animals , Animals, Newborn , Aorta, Thoracic/drug effects , Apoptosis/drug effects , Blotting, Western , Cattle , Cells, Cultured , DNA/analysis , Dose-Response Relationship, Drug , Flow Cytometry , In Situ Nick-End Labeling , In Vitro Techniques , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/metabolism , Proliferating Cell Nuclear Antigen/genetics , Resveratrol
3.
Ann Vasc Surg ; 17(3): 306-14, 2003 May.
Article in English | MEDLINE | ID: mdl-12712371

ABSTRACT

Intraoperative and postoperative arterial ruptures associated with 657 iliac artery balloon dilatation procedures in our department from 1981 to 2000 were prospectively collected and retrospectively analyzed. Our results showed that failure to exercise basic safety principles and the presence of heavily calcified plaque are the major predictors of iliac artery rupture during balloon dilatation. If rupture is contained, surveillance alone is unreliable. Optimal treatment requires temporary hemostasis by balloon tamponade followed by placement of a covered stent to occlude the opening.


Subject(s)
Angioplasty, Balloon/adverse effects , Blood Vessel Prosthesis Implantation/methods , Iliac Artery/injuries , Iliac Artery/surgery , Vascular Diseases/etiology , Vascular Diseases/surgery , Aged , Female , Humans , Iliac Artery/diagnostic imaging , Male , Middle Aged , Radiography , Rupture/diagnostic imaging , Rupture/surgery , Stents , Vascular Diseases/diagnostic imaging
4.
J Endovasc Ther ; 9(2): 203-7, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12010101

ABSTRACT

PURPOSE: To report a case of endograft disintegration misinterpreted as a type II endoleak. CASE REPORT: An 86-year-old man underwent successful Vanguard stent-graft implantation for a 49-mm abdominal aortic aneurysm. At 1 month, a distal type I endoleak was repaired, but another endoleak thought to arise from the lumbar or inferior mesenteric arteries remained. Multiple interventions to embolize the feeding arteries were unsuccessful, and the endoleak persisted. At 1 year, the leak was still present, and the aneurysm had increased to 69 mm. After failing to demonstrate the source of the leak radiographically, surgery was performed. At operation, the endoleak was traced to small holes in the graft fabric. The endograft was removed without difficulty, and the flow was re-established with an aortobi-iliac woven graft. CONCLUSIONS: Chronically implanted stent-grafts can show signs of failure that are confusing or misleading. Correct diagnosis of endoleaks may be difficult, but every effort must be made to identify their source. It is vital that no enlarging aneurysm be left untreated.


Subject(s)
Blood Vessel Prosthesis , Postoperative Complications/diagnostic imaging , Postoperative Complications/surgery , Prosthesis Failure , Stents , Aged , Aged, 80 and over , Aortic Aneurysm, Abdominal/therapy , Diagnosis, Differential , Embolization, Therapeutic , Humans , Lumbosacral Region/blood supply , Male , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...